These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4116584)

  • 1. Thrombin-time test.
    Wessler S; Yin ET; Flute PT; Kakkar VV
    Lancet; 1972 Oct; 2(7782):877-8. PubMed ID: 4116584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of heparin in blood plasma].
    Kotovshchikova MA; Krasko SS
    Lab Delo; 1974; 8(0):460-3. PubMed ID: 4139363
    [No Abstract]   [Full Text] [Related]  

  • 3. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparin-induced impairment of thrombin interaction with fibrinogen and receptors of the anti-coagulation system].
    Strukova SM; Umarova BA; Kulibali M
    Vopr Med Khim; 1986; 32(3):132-6. PubMed ID: 3014736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: The heparin thrombin clotting-time.
    Green PJ
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48020
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
    Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Heparin thrombin clotting-time and platelet factor 4.
    O'Brien JR; Etherington M; Jamieson S; Lawford P
    Lancet; 1974 Sep; 2(7881):656-7. PubMed ID: 4137779
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency.
    Sinauridze EI; Vuimo TA; Tarandovskiy ID; Ovsepyan RA; Surov SS; Korotina NG; Serebriyskiy II; Lutsenko MM; Sokolov AL; Ataullakhanov FI
    Talanta; 2018 Apr; 180():282-291. PubMed ID: 29332812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.
    Schriever HG; Epstein SE; Mintz MD
    Am J Clin Pathol; 1973 Sep; 60(3):323-9. PubMed ID: 4728138
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
    Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
    Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correction between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Pi KD
    Ann Surg; 1983 Jul; 198(1):115. PubMed ID: 6859985
    [No Abstract]   [Full Text] [Related]  

  • 14. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Apr; 51(2):266-8. PubMed ID: 6740558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complexes of heparin with nicotinic acid and nicotinamide and their physiological properties].
    Kudriashov BA; Liapina LA; Kondashevskaia MV
    Dokl Akad Nauk SSSR; 1986; 291(1):242-5. PubMed ID: 2947789
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the blood coagulation and anticoagulation system against a background of narcosis and ganglionic block].
    Seit-Umerov SM; Poliukhov SM; Obydennikova TN
    Vestn Khir Im I I Grek; 1969 Aug; 103(8):16-9. PubMed ID: 4394393
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.